Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDCC Regulatory News (DCC)

Share Price Information for DCC (DCC)

Share Price is delayed by 15 minutes
Get Live Data
6,015.00    -10.00 (-0.17%)
Bid:
6,010.00
Ask:
6,015.00
Spread: 5.00 (0.083%)
Market Cap: £5.14b
DCC Live PriceLast checked at - London Stock Exchange

Intraday DCC Share Chart

Form 8.3 - DCC plc

22 May 2026 12:49

RNS Number : 5038F
Wellington Management Group LLP
22 May 2026
 

FORM 8.3

IRISH TAKEOVER PANEL

OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER

RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER

RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT

SECURITIES REPRESENTING 1% OR MORE

1.

KEY INFORMATION

 

 

(a)

Full name of discloser

Wellington Management Group LLP

 

(b)

Owner or controller of interests and short positions disclosed, if different from 1(a)

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

 

(c)

Name of offeror/offeree in relation to whose relevant securities this form relates

Use a separate form for each offeror/offeree

DCC Public Limited Company

 

(d)

If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree

 

(e)

Date position held/dealing undertaken

For an opening position disclosure, state the latest practicable date prior to the disclosure

21 May 2026

 

(f)

In addition to the company in 1(c) above, is the discloser also making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

NO

 

 

2.

INTERESTS AND SHORT POSITIONS

 

 

If there are interests and short positions to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2 for each additional class of relevant security

 

Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

 

Class of relevant security

€0.25 ordinary shares (IE0002424939)

 

 

Interests

Short Positions

 

 

Number

%

Number

%

 

(1)

Relevant securities owned and/or controlled

1,932,720

2.26 %

50,106

0.06 %

 

(2)

Cash-settled derivatives

 

(3)

Stock-settled derivatives (including options) and agreements to purchase/ sell

 

 

Total

1,932,720

2.26 %

50,106

0.06 %

 

 

 

All interests and all short positions should be disclosed.

Details of options including rights to subscribe for new securities and any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8.

 

 

 

3.

DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

 

(a)

Purchases and sales

 

 

Class of relevant security

Purchase/sale

Number of securities

Price per unit

 

€0.25 ordinary shares (IE0002424939)

Purchase

3,161

61.2782 GBP

 

 

(b)

Cash-settled derivative transactions

 

 

Class of relevant security

Product description e.g. CFD

Nature of dealing e.g. opening/ closing a long/ short position, increasing/ reducing a long/ short position

Number of reference securities

Price per unit

 

 

 

(c)

Stock-settled derivative transactions (including options)

(i)

Writing, selling, purchasing or varying

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii)

Exercise

 

 

Class of relevant security

Product description e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

(d)

Other dealings (including transactions in respect of new securities)

 

 

Class of relevant security

Nature of dealing e.g. subscription, conversion, exercise

Details

Price per unit (if applicable)

 

 

 

4.

OTHER INFORMATION

 

 

(a)

Indemnity and other dealing arrangements

 

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer.

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b)

Agreements, arrangements or understandings relating to options or derivatives

 

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

 

None

 

 

(c)

Attachments

 

 

Is a Supplemental Form 8 attached?

NO

 

 

Date of disclosure

22 May 2026

 

Contact name

Sophie Gray

 

Telephone number

442071266161

 

 

Public disclosures under Rule 8.3 of the Rules must be made to a Regulatory Information Service.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ITPPPURCAUPQGGP
Date   Source Headline
25th Apr 20237:00 amRNSNotice of Full Year 2023 Results
28th Feb 20239:36 amRNSTotal Voting Rights
8th Feb 20237:00 amRNSBoard Appointment
8th Feb 20237:00 amRNSInterim Management Statement
6th Jan 20235:39 pmRNSHolding in Company TR-1
30th Nov 20223:28 pmRNSTotal Voting Rights
14th Nov 20225:43 pmRNSDirector/PDMR Shareholding
8th Nov 20227:00 amRNSResults for the six months ended 30 September 2022
28th Oct 202212:20 pmRNSTotal Voting Rights
21st Oct 202212:19 pmRNSDirector Declaration
29th Sep 20227:16 amRNSDirector Declaration
27th Sep 20227:00 amRNSDCC acquires leading European solar distributor
16th Sep 20224:52 pmRNSHolding in Company TR-1
9th Sep 20225:10 pmRNSHolding in Company TR-1
8th Sep 20224:38 pmRNSHolding in Company TR-1
8th Sep 20227:00 amRNSDCC significantly expands in medical devices
7th Sep 20227:00 amRNSBoard Changes
16th Aug 20225:44 pmRNSHolding in Company TR-1
29th Jul 202211:02 amRNSTotal Voting Rights
26th Jul 20227:08 amRNSDirector Declaration
15th Jul 20223:52 pmRNSResult of AGM
15th Jul 20227:00 amRNSAGM Update
12th Jul 20227:00 amRNS2022 Sustainability Report
8th Jul 20226:11 pmRNSHolding in Company - TR1
30th Jun 20222:59 pmRNSAppointment of Chief Executive Officer, DCC Energy
16th Jun 202210:20 amRNS2022 Annual Report, Notice of AGM and Proxy Form
31st May 20221:19 pmRNSTotal Voting Rights
30th May 20229:00 amRNSDirector/PDMR Shareholding
26th May 20225:41 pmRNSDirector/PDMR Shareholding
17th May 20227:00 amRNSDCC plc Investor Event Today - Leading with Energy
17th May 20227:00 amRNSResults for the year ended 31 March 2022
7th Apr 20227:00 amRNSDCC plc Upcoming Events
28th Feb 202210:44 amRNSTotal Voting Rights
15th Feb 20227:00 amRNSDCC Technology Presentation and Webcast
8th Feb 20227:00 amRNSBoard Changes
8th Feb 20227:00 amRNSInterim Management Statement
3rd Feb 202211:54 amRNSDCC Technology Presentation and Webcast
15th Dec 20217:00 amRNSDCC Management Presentation
15th Dec 20217:00 amRNSDCC plc acquires Almo Corporation
30th Nov 20214:31 pmRNSTotal Voting Rights
26th Nov 20217:15 amRNSDirector Declaration
15th Nov 20214:25 pmRNSDirector/PDMR Shareholding
11th Nov 20214:58 pmRNSDirector/PDMR Shareholding
11th Nov 202111:25 amRNSDirector/PDMR Shareholding
9th Nov 202110:01 amRNSUpdate on Timing of Interim Results Announcement
9th Nov 20217:00 amRNSBoard Changes
9th Nov 20217:00 amRNSResults for the six months ended 30 September 2021
28th Sep 20217:00 amRNSDCC Healthcare Event
14th Sep 20212:33 pmRNSDCC Healthcare Event
16th Jul 20212:17 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.